Patents by Inventor Gloria Acacia BENÍTEZ KING

Gloria Acacia BENÍTEZ KING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414568
    Abstract: The present invention refers to a pharmaceutical composition that comprises the synergistic combination of an antagonist agent of the NMDA receptor, such as the active principle: ketamine and an agonist agent of the MT1 and MT2 melatonin receptors, as is the active principle: melatonin, which are in a pharmaceutical composition, which is indicated for the control and treatment of psychiatric diseases.
    Type: Application
    Filed: July 13, 2023
    Publication date: December 28, 2023
    Applicant: INSTITUTO NACIONAL DE PSIQUIATRÍA "RAMÓN DE LA FUENTE MUÑIZ"
    Inventors: Gloria Acacia BENÍTEZ KING, Margarita Lucía DUBOCOVICH JERKOVICH, Citlali TRUETA SEGOVIA, Marcela VALDÉS TOVAR, Brian Daniel QUERO CHÁVEZ, Ana María DORANTES BARRÓN, Rosa ESTRADA REYES
  • Publication number: 20210046049
    Abstract: The present invention refers to a pharmaceutical composition that comprises the synergistic combination of an antagonist agent of the NMDA receptor, such as the active principle: ketamine and an agonist agent of the MT1 and MT2 melatonin receptors, as is the active principle: melatonin, which are in a pharmaceutical composition, which is indicated for the control and treatment of psychiatric diseases.
    Type: Application
    Filed: February 28, 2019
    Publication date: February 18, 2021
    Applicant: INSTITUTO NACIONAL DE PSIQUIATRÍA "RAMÓN DE LA FUENTE MUÑIZ"
    Inventors: Gloria Acacia BENÍTEZ KING, Margarita Lucía DUBOCOVICH JERKOVICH, Citlali TRUETA SEGOVIA, Marcela VALDÉS TOVAR, Brian Daniel QUERO CHÁVEZ, Ana María DORANTES BARRÓN, Rosa ESTRADA REYES